SiFi vs FNB Local Anesthesia for Hip Fracture Surgeries
Launched by UNIVERSITY OF ALBERTA · Feb 29, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different methods of local anesthesia used during hip fracture surgeries to see which one helps reduce pain more effectively. The two techniques being compared are called the femoral nerve block (FNB) and the suprainguinal fascia iliaca block (SiFi). Both methods are commonly used at the hospital, and the goal is to find out which one leads to less pain after surgery and whether it reduces the need for additional pain medications.
To participate in this trial, you need to be at least 18 years old and scheduled for hip fracture surgery at the University of Alberta Hospital. You should also be able to safely receive a peripheral nerve block, a type of pain relief method. If you have any conditions that would prevent you from using a nerve block or if you do not want to participate, you won't be able to join. If you take part, you'll be randomly assigned to one of the two anesthesia techniques, and your experience will help doctors understand which method is better for managing pain after hip surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 or greater
- • Having hip fracture surgery at the University of Alberta Hospital
- • Suitable for multimodal analgesia including a peripheral nerve block
- Exclusion Criteria:
- • Contraindication to a nerve block technique
- • Refuses consent for a nerve block technique
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported